vs
Cooper Companies (The)（COO）与FactSet（FDS）财务数据对比。点击上方公司名可切换其他公司
Cooper Companies (The)的季度营收约是FactSet的1.8倍（$1.1B vs $607.6M），FactSet净利率更高（25.1% vs 7.9%，领先17.2%），FactSet同比增速更快（6.9% vs 4.6%），Cooper Companies (The)自由现金流更多（$149.9M vs $90.4M），过去两年Cooper Companies (The)的营收复合增速更高（6.9% vs 5.5%）
CooperCompanies是总部位于美国加利福尼亚州圣拉蒙的全球医疗设备企业，旗下设有两大业务单元：主营隐形眼镜生产的库博光学，以及面向女性健康市场提供医疗设备、生育及基因组相关产品的库博外科。
FactSet是总部位于美国康涅狄格州诺沃克的金融数据与软件企业，为客户提供一体化数据及软件解决方案。2024财年，公司年度订阅价值与专业服务营收合计22亿美元，当前总市值约170亿美元。
COO vs FDS — 直观对比
营收规模更大
COO
是对方的1.8倍
$607.6M
营收增速更快
FDS
高出2.3%
4.6%
净利率更高
FDS
高出17.2%
7.9%
自由现金流更多
COO
多$59.5M
$90.4M
两年增速更快
COO
近两年复合增速
5.5%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $607.6M |
| 净利润 | $84.6M | $152.6M |
| 毛利率 | 61.1% | 52.6% |
| 营业利润率 | 13.2% | 31.6% |
| 净利率 | 7.9% | 25.1% |
| 营收同比 | 4.6% | 6.9% |
| 净利润同比 | -28.0% | 1.7% |
| 每股收益（稀释后） | $0.42 | $4.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收COOFDS
| Q4 25 | $1.1B | $607.6M | ||
| Q3 25 | $1.1B | $596.9M | ||
| Q2 25 | $1.0B | $585.5M | ||
| Q1 25 | $964.7M | $570.7M | ||
| Q4 24 | $1.0B | $568.7M | ||
| Q3 24 | $1.0B | $562.2M | ||
| Q2 24 | $942.6M | $552.7M | ||
| Q1 24 | $931.6M | $545.9M |
净利润COOFDS
| Q4 25 | $84.6M | $152.6M | ||
| Q3 25 | $98.3M | $153.6M | ||
| Q2 25 | $87.7M | $148.5M | ||
| Q1 25 | $104.3M | $144.9M | ||
| Q4 24 | $117.5M | $150.0M | ||
| Q3 24 | $104.7M | $89.5M | ||
| Q2 24 | $88.9M | $158.1M | ||
| Q1 24 | $81.2M | $140.9M |
毛利率COOFDS
| Q4 25 | 61.1% | 52.6% | ||
| Q3 25 | 65.3% | 51.6% | ||
| Q2 25 | 67.8% | 52.1% | ||
| Q1 25 | 68.4% | 52.8% | ||
| Q4 24 | 66.5% | 54.5% | ||
| Q3 24 | 66.1% | 54.1% | ||
| Q2 24 | 67.0% | 55.3% | ||
| Q1 24 | 67.0% | 53.3% |
营业利润率COOFDS
| Q4 25 | 13.2% | 31.6% | ||
| Q3 25 | 16.6% | 29.7% | ||
| Q2 25 | 18.4% | 33.2% | ||
| Q1 25 | 18.9% | 32.5% | ||
| Q4 24 | 19.5% | 33.6% | ||
| Q3 24 | 19.2% | 22.7% | ||
| Q2 24 | 17.2% | 36.6% | ||
| Q1 24 | 16.4% | 33.3% |
净利率COOFDS
| Q4 25 | 7.9% | 25.1% | ||
| Q3 25 | 9.3% | 25.7% | ||
| Q2 25 | 8.7% | 25.4% | ||
| Q1 25 | 10.8% | 25.4% | ||
| Q4 24 | 11.5% | 26.4% | ||
| Q3 24 | 10.4% | 15.9% | ||
| Q2 24 | 9.4% | 28.6% | ||
| Q1 24 | 8.7% | 25.8% |
每股收益（稀释后）COOFDS
| Q4 25 | $0.42 | $4.06 | ||
| Q3 25 | $0.49 | $4.03 | ||
| Q2 25 | $0.44 | $3.87 | ||
| Q1 25 | $0.52 | $3.76 | ||
| Q4 24 | $0.59 | $3.89 | ||
| Q3 24 | $0.52 | $2.33 | ||
| Q2 24 | $0.44 | $4.09 | ||
| Q1 24 | $0.41 | $3.65 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $110.6M | $292.7M |
| 总债务越低越好 | $2.5B | $1.4B |
| 股东权益账面价值 | $8.2B | $2.2B |
| 总资产 | $12.4B | $4.2B |
| 负债/权益比越低杠杆越低 | 0.30× | 0.63× |
8季度趋势，按日历期对齐
现金及短期投资COOFDS
| Q4 25 | $110.6M | $292.7M | ||
| Q3 25 | $124.9M | $355.1M | ||
| Q2 25 | $116.2M | $364.0M | ||
| Q1 25 | $100.9M | $287.0M | ||
| Q4 24 | $107.6M | $358.8M | ||
| Q3 24 | $109.7M | $492.6M | ||
| Q2 24 | $112.4M | $522.0M | ||
| Q1 24 | $135.2M | $450.2M |
总债务COOFDS
| Q4 25 | $2.5B | $1.4B | ||
| Q3 25 | $2.4B | $1.4B | ||
| Q2 25 | $2.5B | $1.4B | ||
| Q1 25 | $2.5B | $1.5B | ||
| Q4 24 | $2.6B | $1.4B | ||
| Q3 24 | $2.6B | $1.4B | ||
| Q2 24 | $2.7B | $1.4B | ||
| Q1 24 | $2.7B | $1.5B |
股东权益COOFDS
| Q4 25 | $8.2B | $2.2B | ||
| Q3 25 | $8.4B | $2.2B | ||
| Q2 25 | $8.3B | $2.2B | ||
| Q1 25 | $8.1B | $2.1B | ||
| Q4 24 | $8.1B | $2.0B | ||
| Q3 24 | $7.9B | $1.9B | ||
| Q2 24 | $7.8B | $1.9B | ||
| Q1 24 | $7.7B | $1.8B |
总资产COOFDS
| Q4 25 | $12.4B | $4.2B | ||
| Q3 25 | $12.4B | $4.3B | ||
| Q2 25 | $12.4B | $4.3B | ||
| Q1 25 | $12.2B | $4.2B | ||
| Q4 24 | $12.3B | $4.0B | ||
| Q3 24 | $12.1B | $4.1B | ||
| Q2 24 | $12.0B | $4.0B | ||
| Q1 24 | $12.0B | $4.0B |
负债/权益比COOFDS
| Q4 25 | 0.30× | 0.63× | ||
| Q3 25 | 0.29× | 0.63× | ||
| Q2 25 | 0.30× | 0.66× | ||
| Q1 25 | 0.31× | 0.72× | ||
| Q4 24 | 0.32× | 0.68× | ||
| Q3 24 | 0.33× | 0.71× | ||
| Q2 24 | 0.34× | 0.76× | ||
| Q1 24 | 0.35× | 0.83× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $247.9M | $121.3M |
| 自由现金流经营现金流 - 资本支出 | $149.9M | $90.4M |
| 自由现金流率自由现金流/营收 | 14.1% | 14.9% |
| 资本支出强度资本支出/营收 | 9.2% | 5.1% |
| 现金转化率经营现金流/净利润 | 2.93× | 0.79× |
| 过去12个月自由现金流最近4个季度 | $433.7M | $647.4M |
8季度趋势，按日历期对齐
经营现金流COOFDS
| Q4 25 | $247.9M | $121.3M | ||
| Q3 25 | $261.4M | $212.1M | ||
| Q2 25 | $96.2M | $253.8M | ||
| Q1 25 | $190.6M | $174.0M | ||
| Q4 24 | $268.1M | $86.4M | ||
| Q3 24 | $207.5M | $163.2M | ||
| Q2 24 | $111.0M | $238.2M | ||
| Q1 24 | $122.7M | $143.8M |
自由现金流COOFDS
| Q4 25 | $149.9M | $90.4M | ||
| Q3 25 | $164.5M | $178.1M | ||
| Q2 25 | $18.1M | $228.6M | ||
| Q1 25 | $101.2M | $150.2M | ||
| Q4 24 | $128.1M | $60.5M | ||
| Q3 24 | $118.5M | $137.2M | ||
| Q2 24 | $36.9M | $216.9M | ||
| Q1 24 | $4.6M | $121.9M |
自由现金流率COOFDS
| Q4 25 | 14.1% | 14.9% | ||
| Q3 25 | 15.5% | 29.8% | ||
| Q2 25 | 1.8% | 39.0% | ||
| Q1 25 | 10.5% | 26.3% | ||
| Q4 24 | 12.6% | 10.6% | ||
| Q3 24 | 11.8% | 24.4% | ||
| Q2 24 | 3.9% | 39.2% | ||
| Q1 24 | 0.5% | 22.3% |
资本支出强度COOFDS
| Q4 25 | 9.2% | 5.1% | ||
| Q3 25 | 9.1% | 5.7% | ||
| Q2 25 | 7.8% | 4.3% | ||
| Q1 25 | 9.3% | 4.2% | ||
| Q4 24 | 13.7% | 4.5% | ||
| Q3 24 | 8.9% | 4.6% | ||
| Q2 24 | 7.9% | 3.9% | ||
| Q1 24 | 12.7% | 4.0% |
现金转化率COOFDS
| Q4 25 | 2.93× | 0.79× | ||
| Q3 25 | 2.66× | 1.38× | ||
| Q2 25 | 1.10× | 1.71× | ||
| Q1 25 | 1.83× | 1.20× | ||
| Q4 24 | 2.28× | 0.58× | ||
| Q3 24 | 1.98× | 1.82× | ||
| Q2 24 | 1.25× | 1.51× | ||
| Q1 24 | 1.51× | 1.02× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
COO
| Sphere Other | $365.0M | 34% |
| Toric And Multifocal | $344.7M | 32% |
| Office And Surgical | $214.5M | 20% |
| Fertility | $140.9M | 13% |
FDS
| Americas Segment | $399.7M | 66% |
| EMEA Segment | $149.1M | 25% |
| Asia Pacific Segment | $62.2M | 10% |
